Is there still place for conservative treatment of obesity?;Lo último en diagnóstico y tratamiento de la obesidad. ¿Hay lugar aún para la terapia conservadora?

Revista Medica de Chile

Volumn 133, Issue 6, 2005, Pages 713-722

  Cuevas M, Ada ^a   Reyes S, María Soledad ^b  

^a CLÍNICA LAS CONDES   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

Bariatrics; Diet, reducing; Obesity

Indexed keywords

BARIATRIC SURGERY; BODY MASS; CLASSIFICATION; EXERCISE; FEMALE; HUMAN; MALE; OBESITY; PATIENT CARE; PHYSIOLOGY; REVIEW; SOCIOECONOMICS; TREATMENT OUTCOME; WEIGHT REDUCTION;

BARIATRIC SURGERY; BODY MASS INDEX; EXERCISE; FEMALE; HUMANS; MALE; OBESITY; PATIENT CARE TEAM; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 27744489696     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. FLEGAL KM, CARROLL MD, OGDEN CL, JOHNSON CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-7.
2. MINISTERIO DE SALUD. Encuesta Nacional de Salud, 2003. http://epi.minsal.cl. [Consultado el 01 de marzo, 2005.]
3. COLDITZ GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc 1999; 31(Suppl 11): S663-7.
4. WYNNE K, STANLEY S, MCGOWAN B, BLOOM S. Appetite control. J Endocrinol 2005; 184: 291-318.
5. RANKINEN T, PERUSSE L, WEISNAGEL SJ, SNYDER EE, CHAGNON YC, BOUCHARD C. The human obesity gene map: the 2001 update. Obes Res 2002; 10: 196-243.
6. ROBINSON TM, GRAY RW, YEOMANS MR, FRENCH SJ. Test-meal palatability alters the effects of intragastric fat but not carbohydrate preloads on intake and rated appetite in healthy volunteers. Physiol Behav 2005; 84: 193-203.
7. LATHAM MC. Human nutrition in the developing world. Rome, Italy: Food and Agriculture Organization in the United Nations; 1997.
8. PRENTICE AM, JEBB SA. Obesity in Britain: gluttony or sloth? BMJ 1995; 311: 437-9.
9. WORLD HEALTH ORGANIZATION. The global epidemic of obesity. Genera, Switzerland: World Health Organization; 1997.
10. MANSON JE, WILLETT WC, STAMPFER MJ, COLDITZ GA, HUNTER DJ, HANKINSON SE ET AL. Body weight and mortality among women. N Engl J Med 1995; 333: 677-85.
11. SHAPER AG, WANNAMETHEE SG, WALKER M. Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men. BMJ 1997; 314: 1311-7.
12. ARONNE LJ. Epidemiology, morbidity, and treatment of overweight and obesity. J Clin Psychiatry 2001; 62 (Suppl 23): 13-22.
13. LEAN ME, HAN TS, SEIDELL JC. Impairment of health and quality of life in people with large waist circumference. Lancet 1998; 351: 853-6.
14. LAPIDUS L, BENGTSSON C, LARSSON B, PENNERT K, RYBO E, SJOSTROM L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 years follow up of participants in the population study of women in Gothenburg, Sweden. BMJ 1984; 289: 1257-61.
15. National Task Force on the Prevention and Treatment of Obesity, National Institutes of Health. Very low-calorie diets. JAMA 1993; 270: 967-74.
16. WEINSIER RL, KUSHNER RF. Clinical assessment of obese patients. In: Brownell KD, Fairburn CG, eds. Eating Disorders and Obesity: A Comprehensive Handbook. New York: The Guilford Press; 1995; pp. 512-7.
17. Expert Panel on Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. The practical guide: identification, evaluation and treatment of overweight and obesity in adults. Bethesda, MD. National Heart, Lung, and Blood Institute Obesity Education Initiative, 2002.
18. FREEDMAN MR, KING J, KENNEDY E. Popular diets: a scientific review. Obes Res 2001; 9 (Suppl 1): 1S-40S.
19. DANSINGER ML, GLEASON JA, GRIFFITH JL, SELKER HP, SCHAEFER EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005; 293: 43-53.
20. ST JEOR ST, BRUNNER RL, HARRINGTON ME, SCOTT BJ, DAUGHERTY SA, CUTTER GR ET AL. A classification system to evaluate weight maintainers, gainers, and losers. J Am Diet Assoc 1997; 97: 481-8.
21. POIRIER P, DESPRES JP. Exercise in weight management of obesity. Cardiol Clin 2001; 19: 459-70.
22. WING RR, HILL JO. Successful weight loss maintenance. Annu Rev Nutr 2001; 21: 323-41.
23. Clinical Guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The Evidence Report. National Institutes of Health. Obes Res 1998; 6 (Suppl 2): 51S-209S.
24. RAPOPORT L, CLARK M, WARDLE J. Evaluation of a modified cognitive-behavioural programme for weight management. Int J Obes Relat Metab Disord 2000; 24: 1726-37.
25. SCHEEN AJ, LEFEBVRE PJ. Pharmacological treatment of obesity: present status. Int J Obes Relat Metab Disord 1999; 23 Suppl 1: 47-53.
26. GLAZER G. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. Arch Intern Med 2001; 161: 1814-24.
27. LUQUE CA, REY JA. Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity. Ann Pharmacother 1999; 33: 968-78.
28. JAMES WP, ASTRUP A, FINER N, HILSTED J, KOPELMAN P, ROSSNER S ET AL. Effect of sibutramine on weight maintenance after weight loss: a randomized trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119-25.
29. REIMHERR FW, CUNNINGHAM LA, BATEY SR, JOHNSTON JA, ASCHER JA. A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients. Clin Ther 1998; 20: 505-16.
30. ND, LOGUE EJ, DREZNER MK ET AL. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes Res 2001; 9: 544-51.
31. ANDERSON JW, GREENWAY FL, FUJIOKA K, GADDE KM, MCKENNEY J, O'NEIL PM. Bupropion SR enhances weight loss: a 48-week double-blind, placebo-controlled trial. Obes Res 2002; 10: 633-41.
32. SACHS GS, GUILLE C. Weight gain associated with use of psychotropic medications. J Clin Psychiatry 1999; 60 Suppl 21: 16-9.
33. RICHARD D, FERLAND J, LALONDE J, SAMSON P, DESHAIES Y. Influence of topiramate in the regulation of energy balance. Nutrition 2000; 16: 961-6.
34. YORK DA, SINGER L, THOMAS S, BRAY GA. Effect of topiramate on body weight and body composition of osborne-mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncoupling-protein mRNAs. Nutrition 2000; 16: 967-75.
35. BRAY GA, HOLLANDER P, KLEIN S, KUSHNER R, LEVY B, FITCHET M ET AL. A6 months randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003; 11: 722-33.
36. WILLIAMS CM, ROGERS PJ, KIRKHAM TC. Hyperphagia in pre-fed rats following oral delta9-THC. Physiol Behav 1998; 65: 343-6.
37. KOCH JE. Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets. Pharmacol Biochem Behav 2001; 68: 539-43.
38. COTA D, MARSICANO G, TSCHOP M, GRUBLER Y, FLACHSKAMM C, SCHUBERT M ET AL. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003; 112: 423-31.
39. DESPRÉS JP. CB1 Blockade for de management of Metabolic Risk Disorders. XV International Symposium on Drug affecting Lipid Metabolism. Oct. 2004. Venice, Italy.
40. HECK AM, YANOVSKI JA, CALIS KA. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 2000; 20: 14-9.
41. FINER N, JAMES WP, KOPELMAN PG, LEAN ME, WILLIAMS G. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes Relat Metab Disord 2000; 24: 306-13.
42. HILL JO, HAUPTMAN J, ANDERSON JW, FUJIOKA K, O'NEIL PM, SMITH DK ET AL. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr 1999; 69: 1108-16.
43. ASTRUP A, BREUM L, TOUBRO S, HEIN P, QUAADE F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int J Obes Relat Metab Disord 1992; 16: 269-77.
44. LENZ TL, HAMILTON WR. Supplemental Products Used for weight Loss. J Am Phar Assoc 2004; 44: 59-68.
45. NISOLI E, CARRUBA MO. Emerging aspects of pharmacotherapy for obesity and metabolic syndrome. Pharmacol Res 2004; 50: 453-69.
46. SAMPALIS JS, LIBERMAN M, AUGER S, CHRISTOU NV. The impact of weight reduction surgery on healthcare costs in morbidly obese patients. Obes Surg 2004; 14: 939-47.
47. HE M, STUBBS R. Gastric bypass surgery for severe obesity: what can be achieved? N Z Med J 2004; 117: U1207.
48. BUCHWALD H, AVIDOR Y, BRAUNWALD E, JENSEN MD, PORIES W, FAHRBACH K ET AL. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37.
49. GOLDSTEIN DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992; 16: 397-415.
50. REISIN E, ABEL R, MODAN M, SILVERBERG DS, ELIAHOU HE, MODAN B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 1978; 298: 1-6.
51. WOOD PD, STEFANICK ML, DREON DM, FREY-HEWITT B, GARAY SC, WILLIAMS PT ET AL. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988; 319: 1173-9.
52. KARLSSON J, SJOSTROM L, SULLIVAN M. Swedish obese subjects (SOS) - an intervention study of obesity. Two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes Relat Metab Disord 1998; 22: 113-26.
53. HOLLANDER PA, ELBEIN SC, HIRSCH IB, KELLEY D, MCGILL J, TAYLOR T ET AL. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care 1998; 21: 1288-94.
54. MCTIGUE KM, HARRIS R, HEMPHILL B, LUX L, SUTTON S, BUNTON AJ ET AL. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003; 139: 933-49.
55. DOUKETIS JD, FEIGHTNER JW, ATTIA J, FELDMAN WF. Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health Care. CMAJ 1999; 160: 513-25.
56. PIGNONE MP, AMMERMAN A, FERNÁNDEZ L, ORLEANS CT, PENDER N, WOOLF S ET AL. Counseling to promote a healthy diet in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Am J Prev Med 2003; 24: 75-92.
57. ORZANO AJ, SCOTT JG. Diagnosis and treatment of obesity in adults: an applied evidence-based review. J Am Board Fam Pract 2004; 17: 359-69.